Mei‐chin Yin

7.9k citations
129 papers · 6.5k indexed · h-index 51

Mei‐chin Yin

129 papers receiving 6.2k citations

Peers

Mei‐chin Yin
Comparison fields: 5 of 145
  • Biochemistry 994
  • Pharmacology 718
  • Complementary and alternative medicine 417
  • Clinical Biochemistry 337
  • Animal Science and Zoology 487
Replace Toshiro Matsui with:
Toshiro Matsui Japan
Kiyotaka Nakagawa Japan
Mi‐Kyung Lee South Korea
Wen‐Chi Hou Taiwan
Christian Demigné France
Han Geuk Seo South Korea
Lilian U. Thompson Canada
Michihiro Sugano Japan
Siegfried Wolffram Germany
Ian T. Johnson United Kingdom
Mei‐chin Yin relative to Toshiro Matsui Japan Toshiro Matsui's profile →
Citations per field
00.5×1.5×2.4×
Toshiro Matsui · 1×
Citations per year

Countries citing papers authored by Mei‐chin Yin

Since Specialization
Citations

This map shows the geographic impact of Mei‐chin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐chin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐chin Yin more than expected).

Fields of papers citing papers by Mei‐chin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐chin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐chin Yin. The network helps show where Mei‐chin Yin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mei‐chin Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mei‐chin Yin Line = papers co-authored together Mei‐chin Yin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20199
3 201725
4 201631
5 201456
6 201425
7 201245
8 201251
9 20115
10 200995
11 200995
12 200884
13 200817
14 200856
15 200831
16 2006103
17 200455
18 200457
19 200225
20 1999129

About Mei‐chin Yin

Mei‐chin Yin is a scholar working on Clinical Biochemistry, Biochemistry and Pharmacology, having authored 129 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (18 papers), Biochemical effects in animals (17 papers), Garlic and Onion Studies (16 papers), Natural product bioactivities and synthesis (16 papers), Natural Antidiabetic Agents Studies (15 papers), Antioxidant Activity and Oxidative Stress (10 papers), Aldose Reductase and Taurine (10 papers) and Phytochemicals and Antioxidant Activities (9 papers). The work is most often cited by research in Biochemistry (994 citations), Pharmacology (718 citations) and Complementary and alternative medicine (417 citations). Mei‐chin Yin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mei‐Chin Mong, Shih-Jei Tsai, Cheng‐Chin Hsu, Kung‐Chi Chan, Wen‐Hu Liu, Che‐Yi Chao, Chia-Yu Lin, Chun‐Yin Huang, C. Faustman and Chun-Che Lin. Their work appears in journals such as Journal of Food Science, Journal of Agricultural and Food Chemistry, Biomedicine, Food and Chemical Toxicology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026